Please use this identifier to cite or link to this item:
https://doi.org/10.1016/S1097-2765(03)00490-8
Title: | Regulation of NF-κB Signaling by Pin1-Dependent Prolyl Isomerization and Ubiquitin-Mediated Proteolysis of p65/RelA | Authors: | Ryo, A. Suizu, F. Perrem, K. Liou, Y.-C. Wulf, G. Lu, K.P. Yoshida, Y. Rottapel, R. Yamaoka, S. |
Issue Date: | 2003 | Citation: | Ryo, A., Suizu, F., Perrem, K., Liou, Y.-C., Wulf, G., Lu, K.P., Yoshida, Y., Rottapel, R., Yamaoka, S. (2003). Regulation of NF-κB Signaling by Pin1-Dependent Prolyl Isomerization and Ubiquitin-Mediated Proteolysis of p65/RelA. Molecular Cell 12 (6) : 1413-1426. ScholarBank@NUS Repository. https://doi.org/10.1016/S1097-2765(03)00490-8 | Abstract: | The transcription factor NF-κB is activated by the degradation of its inhibitor IκBα, resulting in its nuclear translocation. However, the mechanism by which nuclear NF-κB is subsequently regulated is not clear. Here we demonstrate that NF-κB function is regulated by Pin1-mediated prolyl isomerization and ubiquitin-mediated proteolysis of its p65/RelA subunit. Upon cytokine treatment, Pin1 binds to the pThr254-Pro motif in p65 and inhibits p65 binding to IκBα, resulting in increased nuclear accumulation and protein stability of p65 and enhanced NF-κB activity. Significantly, Pin1-deficient mice and cells are refractory to NF-κB activation by cytokine signals. Moreover, the stability of p65 is controlled by ubiquitin-mediated proteolysis, facilitated by a cytokine signal inhibitor, SOCS-1, acting as a ubiquitin ligase. These findings uncover two important mechanisms of regulating NF-κB signaling and offer new insight into the pathogenesis and treatment of some human diseases such as cancers. | Source Title: | Molecular Cell | URI: | http://scholarbank.nus.edu.sg/handle/10635/38232 | ISSN: | 10972765 | DOI: | 10.1016/S1097-2765(03)00490-8 |
Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.